Breakthrough brings hope for triple-negative breast cancer
Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks estrogen, progesterone, and HER2 receptors, making it resistant to many traditional hormone and targeted therapies.